{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:28:13Z","timestamp":1793327293082,"version":"4.5.0"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver Transpl"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Clinical indications for liver transplantation (LT) in patients with autoimmune hepatitis (AIH) are identical to those of patients with other chronic liver diseases that end in acute or semiacute liver failure, decompensated cirrhosis, or hepatocellular carcinoma. Recurrent disease after LT has been reported in 10%\u201050% of patients with AIH, and the frequency of detection is influenced in part by the use of protocol or clinically indicated liver biopsy. De novo AIH connotes the development of AIH in patients transplanted for liver diseases other than AIH, and it has been reported in 5%\u201010% of pediatric and 1%\u20102% of adult recipients. Recurrent disease can negatively impact on graft and patient survival, and retransplantation has been required in 8%\u201023%. De novo AIH is within the spectrum of graft dysfunction that includes plasma cell\u2013rich rejection, and it can also progress to cirrhosis and graft failure. Treatment for recurrent or de novo disease is based on the conventional regimens for AIH, and corticosteroid therapy alone or combined with azathioprine is standard. Better control of disease activity prior to LT has been associated with less recurrence, and maintenance corticosteroid treatment after LT can reduce its frequency. In conclusion, recurrent AIH is far more frequent than de novo AIH. Both may have negative impacts on graft and patient survival, and early detection and treatment are key objectives. Future investigations must codify the diagnostic criteria for each graft dysfunction, seek diagnostic biomarkers, and evaluate treatments that improve outcomes without increasing the risk of pre\u2010 and post\u2010LT infections.<\/jats:p>","DOI":"10.1002\/lt.25375","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T11:58:12Z","timestamp":1540900692000},"page":"152-166","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Recurrent and De Novo Autoimmune Hepatitis"],"prefix":"10.1097","volume":"25","author":[{"given":"Guido","family":"Stirnimann","sequence":"first","affiliation":[{"name":"Department of Visceral Surgery and Medicine,Inselspital Bern, Bern University Hospital and University of Bern,Bern,Switzerland"},{"name":"Division of Gastroenterology and Liver Unit,University of Alberta Hospital,Edmonton,Alberta,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ebadi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Unit,University of Alberta Hospital,Edmonton,Alberta,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Czaja","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Mayo Clinic College of Medicine and Science,Rochester,MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-7980","authenticated-orcid":false,"given":"Aldo J.","family":"Montano\u2010Loza","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Unit,University of Alberta Hospital,Edmonton,Alberta,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"lt25375-bib-0001-20240115","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"lt25375-bib-0002-20240115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"lt25375-bib-0003-20240115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"lt25375-bib-0004-20240115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cld.2011.08.008","article-title":"Recurrent and de novo autoimmune liver diseases","volume":"15","year":"2011","journal-title":"Clin Liver Dis"},{"key":"lt25375-bib-0005-20240115","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0006-20240115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"issue":"suppl 2","key":"lt25375-bib-0007-20240115","first-page":"S25","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0008-20240115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/187152808784165225","article-title":"Liver tolerance and the manipulation of immune outcomes","volume":"7","year":"2008","journal-title":"Inflamm Allergy Drug Targets"},{"key":"lt25375-bib-0009-20240115","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-2007-979471","article-title":"The liver: a special case in transplantation tolerance","volume":"27","year":"2007","journal-title":"Semin Liver Dis"},{"key":"lt25375-bib-0010-20240115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200008150-00014","article-title":"Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors","volume":"70","year":"2000","journal-title":"Transplantation"},{"key":"lt25375-bib-0011-20240115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De\u2010novo autoimmune hepatitis after liver transplantation","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"lt25375-bib-0012-20240115","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2012.02832.x","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"lt25375-bib-0013-20240115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"lt25375-bib-0014-20240115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"19","year":"2015","journal-title":"Clin Liver Dis"},{"key":"lt25375-bib-0015-20240115","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s10620-014-3473-z","article-title":"Cell mediators of autoimmune hepatitis and their therapeutic implications","volume":"60","year":"2015","journal-title":"Dig Dis Sci"},{"key":"lt25375-bib-0016-20240115","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"lt25375-bib-0017-20240115","first-page":"292","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","year":"1987","journal-title":"Lancet"},{"key":"lt25375-bib-0018-20240115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver\u2010pancreas antibodies in autoimmune hepatitis","volume":"18","year":"1993","journal-title":"Hepatology"},{"key":"lt25375-bib-0019-20240115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0016-5085(99)70095-8","article-title":"Glutathione S\u2010transferase as a major autoantigen in anti\u2010SLA\u2010positive autoimmune hepatitis","volume":"116","year":"1999","journal-title":"Gastroenterology"},{"key":"lt25375-bib-0020-20240115","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the Model for End\u2010Stage Liver Disease","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"lt25375-bib-0021-20240115","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","article-title":"Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"lt25375-bib-0022-20240115","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1478-3231.2005.01121.x","article-title":"Early treatment response predicts the need for liver transplantation in autoimmune hepatitis","volume":"25","year":"2005","journal-title":"Liver Int"},{"key":"lt25375-bib-0023-20240115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","year":"2016","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0024-20240115","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","year":"1998","journal-title":"Transplantation"},{"key":"lt25375-bib-0025-20240115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","year":"1999","journal-title":"Transplantation"},{"issue":"pt 1","key":"lt25375-bib-0026-20240115","first-page":"693","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","year":"2000","journal-title":"Hepatology"},{"key":"lt25375-bib-0027-20240115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0028-20240115","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","year":"2003","journal-title":"Gut"},{"key":"lt25375-bib-0029-20240115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1272834","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"31","year":"2011","journal-title":"Semin Liver Dis"},{"key":"lt25375-bib-0030-20240115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/jlts.2002.33485","article-title":"Autoimmune hepatitis after liver transplantation and other lessons of self\u2010intolerance","volume":"8","year":"2002","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0031-20240115","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.4049\/jimmunol.173.9.5355","article-title":"Cutting edge: identification of hepatitis C virus\u2010specific CD8+ T cells restricted by donor HLA alleles following liver transplantation","volume":"173","year":"2004","journal-title":"J Immunol"},{"key":"lt25375-bib-0032-20240115","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3748\/wjg.v22.i10.2906","article-title":"De novo autoimmune hepatitis in liver transplant: state\u2010of\u2010the\u2010art review","volume":"22","year":"2016","journal-title":"World J Gastroenterol"},{"key":"lt25375-bib-0033-20240115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune\u2010mediated diseases: implications for immunotherapy","volume":"2","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"lt25375-bib-0034-20240115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2011.06.005","article-title":"Epitope spreading of the anti\u2010CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model","volume":"37","year":"2011","journal-title":"J Autoimmun"},{"key":"lt25375-bib-0035-20240115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"lt25375-bib-0036-20240115","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.151.2.1039","article-title":"Cyclosporin A\u2010induced autoimmune disease in mice","volume":"151","year":"1993","journal-title":"J Immunol"},{"key":"lt25375-bib-0037-20240115","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1600-6143.2007.01881.x","article-title":"Effects of cyclosporine on transplant tolerance: the role of IL\u20102","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"lt25375-bib-0038-20240115","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","article-title":"Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation","volume":"57","year":"2012","journal-title":"Dig Dis Sci"},{"key":"lt25375-bib-0039-20240115","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","year":"1999","journal-title":"J Hepatol"},{"key":"lt25375-bib-0040-20240115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"lt25375-bib-0041-20240115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.21280","article-title":"for Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"lt25375-bib-0042-20240115","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/lt.21518","article-title":"Plasma cell hepatitis in liver allografts: variant of rejection or autoimmune hepatitis?","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0043-20240115","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0044-20240115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00005176-199707000-00003","article-title":"Recurrence of autoimmune hepatitis in children after liver transplantation","volume":"25","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"lt25375-bib-0045-20240115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long\u2010term pathologic study","volume":"32","year":"2000","journal-title":"Hepatology"},{"key":"lt25375-bib-0046-20240115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1196\/annals.1398.041","article-title":"Identification by proteomic tool of atypical anti\u2010liver\/kidney microsome autoantibodies targets in de novo autoimmune hepatitis after liver transplantation","volume":"1109","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"lt25375-bib-0047-20240115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1399-3046.2005.00470.x","article-title":"Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation","volume":"10","year":"2006","journal-title":"Pediatr Transplant"},{"key":"lt25375-bib-0048-20240115","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","year":"2001","journal-title":"Transplantation"},{"key":"lt25375-bib-0049-20240115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1399-0012.2007.00787.x","article-title":"De novo autoimmune hepatitis following living\u2010donor liver transplantation for primary biliary cirrhosis","volume":"22","year":"2008","journal-title":"Clin Transplant"},{"key":"lt25375-bib-0050-20240115","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/j.transproceed.2010.08.062","article-title":"De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report","volume":"42","year":"2010","journal-title":"Transplant Proc"},{"key":"lt25375-bib-0051-20240115","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3748\/wjg.v13.i10.1618","article-title":"Recurrence of autoimmune hepatitis after liver transplantation without elevation of alanine aminotransferase","volume":"13","year":"2007","journal-title":"World J Gastroenterol"},{"key":"lt25375-bib-0052-20240115","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1600-6143.2010.03080.x","article-title":"Phenotypic expression of recurrent disease after liver transplantation","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"lt25375-bib-0053-20240115","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long\u2010term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"lt25375-bib-0054-20240115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00007890-198404000-00009","article-title":"Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting","volume":"37","year":"1984","journal-title":"Transplantation"},{"key":"lt25375-bib-0055-20240115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2006.092064","article-title":"High incidence of allograft dysfunction in liver transplanted patients treated with pegylated\u2010interferon alpha\u20102b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?","volume":"56","year":"2007","journal-title":"Gut"},{"key":"lt25375-bib-0056-20240115","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/lt.20209","article-title":"Glutathione S\u2010transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation","volume":"10","year":"2004","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0057-20240115","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/lt.21721","article-title":"Risk factors for developing de novo autoimmune hepatitis associated with anti\u2010glutathione S\u2010transferase T1 antibodies after liver transplantation","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0058-20240115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1600-6143.2006.01717.x","article-title":"Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"lt25375-bib-0059-20240115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in living\u2010donor liver transplantation","volume":"78","year":"2004","journal-title":"Transplantation"},{"key":"lt25375-bib-0060-20240115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00007890-200301150-00024","article-title":"Impact of human leukocyte antigen matching in liver transplantation","volume":"75","year":"2003","journal-title":"Transplantation"},{"key":"lt25375-bib-0061-20240115","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/lt.21809","article-title":"Recurrent autoimmune hepatitis after liver transplantation: a disease continuum or a fresh start?","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0062-20240115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients","volume":"8","year":"2002","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0063-20240115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00007890-199701270-00012","article-title":"Weaning of immunosuppression in liver transplant recipients","volume":"63","year":"1997","journal-title":"Transplantation"},{"key":"lt25375-bib-0064-20240115","first-page":"2811","article-title":"Cyclosporine\u2010induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibility class II\u2010dependent autoaggression","volume":"25","year":"1993","journal-title":"Transplant Proc"},{"key":"lt25375-bib-0065-20240115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500050514","article-title":"Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis","volume":"5","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"lt25375-bib-0066-20240115","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.transproceed.2007.02.030","article-title":"Liver transplantation for autoimmune hepatitis: a single\u2010center experience","volume":"39","year":"2007","journal-title":"Transplant Proc"},{"key":"lt25375-bib-0067-20240115","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cgh.2011.10.028","article-title":"Autoimmune hepatitis after liver transplantation","volume":"10","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt25375-bib-0068-20240115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1399-3046.2004.00230.x","article-title":"Utility of azathioprine metabolite measurements in post\u2010transplant recurrent autoimmune and immune\u2010mediated hepatitis","volume":"8","year":"2004","journal-title":"Pediatr Transplant"},{"key":"lt25375-bib-0069-20240115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post\u2010transplant autoimmune hepatitis","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"lt25375-bib-0070-20240115","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/TP.0b013e31821841ba","article-title":"The pattern of late mortality in liver transplant recipients in the United Kingdom","volume":"91","year":"2011","journal-title":"Transplantation"},{"key":"lt25375-bib-0071-20240115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults","volume":"34","year":"2001","journal-title":"Hepatology"},{"key":"lt25375-bib-0072-20240115","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 Comprehensive update of the Banff Working Group on Liver Allograft Pathology: introduction of antibody\u2010mediated rejection","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"lt25375-bib-0073-20240115","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1572-0241.2002.06052.x","article-title":"Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature","volume":"97","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"lt25375-bib-0074-20240115","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"lt25375-bib-0075-20240115","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0041-1345(00)02826-8","article-title":"A cause of late graft dysfunction after liver transplantation in children: de\u2010novo autoimmune hepatitis","volume":"33","year":"2001","journal-title":"Transplant Proc"},{"key":"lt25375-bib-0076-20240115","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.transproceed.2011.05.030","article-title":"De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution\u2019s experience","volume":"43","year":"2011","journal-title":"Transplant Proc"},{"key":"lt25375-bib-0077-20240115","doi-asserted-by":"crossref","first-page":"e12945","DOI":"10.1111\/petr.12945","article-title":"Long\u2010term outcomes of de novo autoimmune hepatitis in pediatric liver transplant recipients","volume":"21","year":"2017","journal-title":"Pediatr Transplant"},{"issue":"pt 2","key":"lt25375-bib-0078-20240115","first-page":"e165","article-title":"De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4\u2010related immune disease","volume":"23","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"lt25375-bib-0079-20240115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-0012.2007.00667.x","article-title":"Clinical relevance of autoantibodies after pediatric liver transplantation","volume":"21","year":"2007","journal-title":"Clin Transplant"},{"key":"lt25375-bib-0080-20240115","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment\u2010naive patients","volume":"55","year":"2011","journal-title":"J Hepatol"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.25375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lt.25375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/lt.25375","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201901000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T01:29:00Z","timestamp":1705282140000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201901000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.25375","relation":{},"ISSN":["1527-6465","1527-6473"],"issn-type":[{"value":"1527-6465","type":"print"},{"value":"1527-6473","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}